Suppr超能文献

术后患者瑞芬太尼诱发痛觉过敏的队列研究

[Cohort study of remifentanil-induced hyperalgesia in postoperative patients].

作者信息

Ma Jian-feng, Huang Zhi-lian, Li Jun, Hu She-jun, Lian Qing-quan

机构信息

Department of Anesthesiology, Second Affiliated Hospital & Yuying Children Hospital of Wenzhou Medical College, Wenzhou 325027, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2011 Apr 12;91(14):977-9.

Abstract

OBJECTIVE

To investigate the incidence of remifentanil-induced hyperalgesia and screen for the relevant influencing factors in the post-operative patients.

METHODS

A total of 1620 patients from June 2008 to December 2008 in our hospital undergoing general anesthesia with remifentanil and whose length of operative incision was less than 4 cm were enrolled. The incidence of postoperative hyperalgesia was investigated and recorded at the timepoints of staying at post-anesthesia care unit (PACU), 4 h and 24 h postoperation respectively. The unconditional statistical analysis of Logistic regression was used to explore such possible influencing factors as age, gender, methods of general anesthesia, operative duration, operative sites and remifentanil dose.

RESULTS

The incidence of postoperative remifentanil-induced hyperalgesia was 16.1% (n = 261). The incidence of postoperative hyperalgesia was significantly increased in patients < 16 yrs (25.9%) vs ≥ 16 yrs (15.6%) (P < 0.05), males vs females (20.8% vs 13.0%, P < 0.01), operative duration > 2 h (32.7%) vs ≤ 2 h (9.9%) (P < 0.01) and remifentanil dose > 30 µg/kg (41.8%) vs ≤ 30 µg/kg (4.8%) (P < 0.01). And the incidence of limb protective action, touch and cold-induced allodynia were the two highest indicators (39.0%, 34.5%). Analysis of Logistic regression showed that ages under 16 years old, operative duration > 2 h and remifentanil dose > 30 µg/kg were relevant with hyperalgesia (all P < 0.05).

CONCLUSION

Ages under 16 years old, operative duration and remifentanil dose are the risk factors for postoperative remifentanil-induced hyperalgesia. Neither methods of general anesthesia nor operative sites has any effect on the occurrence of hyperalgesia.

摘要

目的

探讨瑞芬太尼诱发痛觉过敏的发生率,并筛选术后患者的相关影响因素。

方法

选取2008年6月至2008年12月在我院行全身麻醉且使用瑞芬太尼、手术切口长度小于4 cm的1620例患者。分别于麻醉后恢复室(PACU)停留时、术后4 h和24 h调查并记录术后痛觉过敏的发生率。采用Logistic回归无条件统计分析,探讨年龄、性别、全身麻醉方式、手术时长、手术部位和瑞芬太尼剂量等可能的影响因素。

结果

术后瑞芬太尼诱发痛觉过敏的发生率为16.1%(n = 261)。年龄<16岁患者术后痛觉过敏发生率(25.9%)显著高于≥16岁患者(15.6%)(P < 0.05),男性高于女性(20.8% 对13.0%,P < 0.01),手术时长>2 h患者(32.7%)高于≤2 h患者(9.9%)(P < 0.01),瑞芬太尼剂量>30 μg/kg患者(41.8%)高于≤30 μg/kg患者(4.8%)(P < 0.01)。肢体保护动作、轻触和冷诱发痛觉异常的发生率是两项最高指标(39.0%,34.5%)。Logistic回归分析显示,16岁以下、手术时长>2 h和瑞芬太尼剂量>30 μg/kg与痛觉过敏相关(均P < 0.05)。

结论

16岁以下、手术时长和瑞芬太尼剂量是术后瑞芬太尼诱发痛觉过敏的危险因素。全身麻醉方式和手术部位均对痛觉过敏的发生无影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验